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Abstract
Background: Metastatic disease to the shoulder girdle is a challenging problem because of the
potential for pain, pathologic fracture and loss of function of that limb. Management of the bone
disease centers around palliation, prevention of further complications and the preservation of
residual function. A variety of surgical options exist for managing metastatic disease to the shoulder
girdle and our experience with over 90 patients is reported. We focus on a preferred technique of
combining rigid intramedullary nailing with cementation.
Methods: Patients with metastatic disease to the shoulder girdle were accrued over a 9 year
period from 1996 to 2004. 93 patients were identified with 96 operations being performed. The
median age was 63 years (range 33 – 89) and 54% were female. The commonest primary tumor to
metastasize was breast, and the proximal and midshaft humerus was involved in 84% of cases. The
median survival time was 8 months and at last review 82% of patients had died of their disease
Results: Operations performed were intramedullary nailing (n = 51), resection with or without
prosthetic reconstruction (n = 34) or plate osteosynthesis (n = 9). The site of the metastasis was
a guide to the most appropriate operation. Amputations (n = 2) were not done as the primary
procedure.
Median post operative hospitalization ranged from 3 to 6 days depending on the type of operation
performed. Our preferred technique for diaphyseal lesions (intramedullary nailing plus
cementation) achieved excellent results in terms of pain relief, functional restoration and minimal
complications. Functional restriction was most notable for proximal humeral prostheses (35% of
patients).
Conclusion: Surgical treatment of metastases to the shoulder girdle can be successful, allowing
prompt relief of pain and return to prehospital level of care. Proximal and midshaft humeral
metastases are easily amenable to resection and reconstruction or intramedullary nailing with
cementation. Relief of pain and preservation of function occurs for the majority of patients.
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Background
Metastatic disease is the most common malignant bone
tumor [1], with the humerus being the second most com-
mon long bone to be involved after the femur [1-3]. This
can result in pain, loss of function and pathological frac-
ture. The healing potential of pathologically fractured
bone is low, hence the need for operative intervention in
many of these patients. A functional upper limb is pivotal
to a patients' independence, therefore, preserving limb
function is a major goal of treatment.
A review of the literature over the past 20 years has shown
a lack of published studies with adequate numbers of
patients. Lewallen et al [4] reported their outcomes on 54
patients with humeral fractures in 1982. Our study, the
largest to date, examines the different types of operative
treatments for metastatic disease to the upper limb in 93
patients. Specifically, we have focused on a preferred tech-
nique of augmenting rigid intramedullary fixation with
cementation.
Patients and methods
Patients with metastatic disease to the humerus who
underwent operative treatment were identified from the
audit database of the Department of Orthopedics at St
Vincent's hospital, Melbourne, a tertiary referral centre for
the management of bone and soft tissue tumors. The set-
ting is retrospective and the information was mainly from
case records. Bony metastases to the humerus are rare and
running a prospective study for many years would be dif-
ficult.
The patients were accrued over a 9 year period, from Jan
1996 to Dec 2004. Information was gathered from the
medical records and this included patient demographics,
site of metastasis, primary tumor, operative details
(including length of operation), length of post operative
stay and any complications. Outcome measures of pain
and function were assessed subjectively by the patients
and recorded by the examiner at the time of review. The
data was obtained from the most recent clinical review
appointment documented in the history. Because of the
variability in accurately assessing degree of severity of the
pain, we chose to record patients as either having no pain
or pain which was causing them discomfort. Patients had
restricted function if they were unable to use the affected
limb in the usual manner.
Patients
93 patients were identified from our database with 96
operations being performed. 2 patients required revision
surgery and 1 had bilateral humeral metastases which
were operated on. The median age was 63 (range: 33 – 89)
years with 54% female.
Primary tumors Figure 1
Primary tumors. Primary tumors which have metastasized to the shoulder girdle. The number above the columns repre-
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Presenting symptoms
Pathologic fracture was the commonest presentation (52
patients, 56%). Pain without fracture was the main pre-
senting complaint in 41% of cases. Only 2 patients pre-
sented with a painless lump in the arm.
Tumour type and location
Breast carcinoma was the commonest histotype with
almost 25% of patients presenting with this diagnosis.
Myeloma, renal and lung carcinoma were the next most
common diagnoses (Figure 1). Almost 90% of tumors
were located in the diaphyseal (middle third) or proximal
(proximal third) humerus (47% and 42% respectively).
Distal humeral (distal third) metastases were uncommon,
with 11% involvement. Scapular and clavicle involve-
ment was rare (4% and 2% respectively)
Surgery
The most common procedure was the insertion of a rigid
intramedullary rod and the second most common proce-
dure was resection of the metastatic lesion and prosthetic
reconstruction (Table 1). Plate osteosynthesis was pre-
dominantly used for diaphyseal and distal humeral
lesions. The location of the tumor in the humerus was a
significant determinant of the type of operative procedure
performed.
Intramedullary nailing was performed in 51 cases mainly
for diaphyseal lesions and in some proximal lesions
where there was sufficient normal proximal bone for the
rod to span. The Alta intramedullary rod (Stryker How-
medica Osteonics, Mahwah, NJ) with methylmethacrylate
bone cement (Edurance, DePuy, Warsaw, IN) was used in
44 cases. The Alta rod was chosen because of its fluted
design which allows backflow of cement on insertion
(Figure 2). 4 cases used the Fixion inflatable rod (Disc-O-
Tech Medical Technologies, Herzliya, Israel). The remain-
ing 3 cases each utilized another type of rigid intramedul-
lary rod with interlocking screws. The choice of rod used
was determined by the operating surgeon. 8 cases were
done via an open technique, with curettage of the tumor
cavity and reduction of the fracture. The open technique
was used if the fracture was unable to be reduced closed
(due to comminution or marked displacement) or if the
fracture or bone defect is adjacent to the path of the radial
nerve as it winds posterior around the humeral shaft. By
formally exposing the fracture, the nerve is able to be pro-
tected from potential cement injury and good alignment
of the fracture can be maintained when inserting the rod
and curing of the cement.
Prior to insertion of the intramedullary rod, the humeral
canal was reamed and irrigated. A suction catheter was
placed in the canal and low viscosity cement with Gen-
tamycin antibiotic (Endurance, DePuy, Warsaw, IN) was
injected into the proximal entry hole. The intramedullary
rod was inserted while the cement was still wet in order to
reduce the risk of pulmonary embolic phenomenon [5,6].
Recognizing that the tumors were metastatic carcinomas,
and in all cases, treatment was for palliation, the aim of
surgical margins when inserting a prostheses was to pre-
serve as much bone as was reasonably possible and also to
preserve and reconstruct the rotator cuff. A variety of pros-
theses were used with cementation of the stem to the
shaft. Proximal prostheses were used if there was involve-
ment of the humeral head or insufficient healthy bone to
allow proximal purchase of an intramedullary rod. There
were 20 Isoelastic proximal humeral replacements
(Mathys, Bettlach, Switzerland) and 2 Neer II (Smith and
Nephew, Mansfield, MA) prostheses. Not all of the proxi-
mal humeral prostheses have the facility to repair the
residual rotator cuff to the prosthesis. If suture holes are
available to reconstruct the capsule or rotator cuff to the
prosthesis, then this should be done to enable greater sta-
bility at the shoulder. If no suture holes are available, then
nylon mesh fixed around the proximal part of the prosthe-
sis can be used as a reliable anchoring site onto which cap-
sular or rotator cuff fixation may be performed.
Stabilizing the shoulder allows more useful function of
the hand and elbow, and decreases the "dragging sensa-
tion" that some patients experience with inferiorly sublux-
ing prostheses.
2 intercalary prostheses were used for diaphyseal lesions.
Distal lesions treated with prosthetic reconstructions used
a total elbow replacement system (Zimmer, Warsaw, IN).
Scapular lesions were treated with scapulectomy in con-
Table 1: Relationship of operations performed to the site of metastses
Proximal humerus Midshaft humerus Distal humerus Clavicle Scapula Total
Intramedullary rod 14 37 0 0 0 51
Plate and screws 0 2 6 1 0 9
Resection & prosthesis 22 2 4 0 2 30
R e s e c t i o n  a l o n e 2 0 0 114
Amputation 1 1 0 0 0 2
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junction with proximal humeral resection and recon-
structed using scapular prostheses with a proximal
humeral prosthesis.
Plate and screw fixation was performed after curettage,
dental burring, treatment with phenol and alcohol and
finally, cementation of the bone defect. This was per-
formed mainly for distal lesions. Plate osteosynthesis for
diaphyseal lesions was only performed in 2 cases.
Amputations were not done as primary procedures. The 2
cases involved were due to complications of previous
intramedullary nailing. One patient had extensive local
tumor compression of the axillary neurovascular bundle 6
months following the primary procedure, resulting in
gangrene of the arm. The other patient had a previous
intramedullary rod which was causing persistent pain. The
primary tumor involved was breast and renal carcinoma
respectively.
Results
Of the 93 patients, 76 (82 %) had died of disease. The
remaining 17 patients were alive at the time of the study
or no mortality data was available. Mortality data was
obtained from the patients' medical records or from the
State registry of births, deaths and marriages. The mean
length of follow up for the patients who were still alive
was 31.7 months (The longest period of follow up being
58 months). The mean survival time of the patients who
died was 13.2 months with a maximum of 51 months.
50% of patients were still alive 8 months after surgery
(Figure 3).
Operative time and length of stay
The operative time was recorded from the time of skin
preparation to application of the dressing. Prosthetic
reconstructions took the longest operative time for com-
pletion (median 150 minutes) while insertion of
intramedullary fixation was the quickest (median 75 min-
utes). A similar pattern was noted for length of acute hos-
pital stay. The longest median time for hospital stay
following resection and prosthetic reconstruction was 6
days compared to a median of 3 days for intramedullary
nailing.
Pain control and function
Pain control was very good after intramedullary rod inser-
tion and prosthetic reconstruction with only 8% and 13%
respectively of patients having any persistent post-opera-
tive pain (Table 2). Restriction of any function was the
highest after prosthetic replacement (35% for proximal
prostheses, see Table 2).
Complications
Nerve palsy was the commonest complication (6 %) and
the radial nerve was the one affected (Table 3). Another
important and unexpected complication was pulmonary
embolic phenomenon which was observed in two cases.
Re-operations were performed in 2 patients (Table 2), one
in a patient who had intramedullary nailing, the other in
a patient who had a total elbow replacement for a distal
humeral lesion. The first patient had local vascular inva-
sion of the tumor resulting in gangrene of the arm neces-
sitating amputation. The second patient had loosening of
their prosthesis 2 years after the initial surgery and was
changed to a long stem Conrad-Morrey elbow replace-
ment (Zimmer, Warsaw, IN).
Discussion
Our results show that half of patients with metastatic dis-
ease to the upper limb remain alive at 8 months, with a
mean of 13.2 months. These patients thus deserve ade-
quate treatment of their disease despite being generally
palliative. Adequate treatment should involve surgical
intervention as conservative management (splints or
casts) of these fractures has shown poor results. Fleming et
al [7] demonstrated non union in 50% of cases and inad-
equate pain relief in 88% with conservative measures.
Pain, whether it be a result of a fracture or not, was a sig-
nificant presenting symptoms in all but 2 of our patients.
The surgical options addresses the primary aim of pain
control, but also needs to be durable enough to allow
early mobilisation in pathologically weakened bone to
preserve limb function.
The majority of our patients had treatment for pathologic
fracture (56%). Prophylactic treatment has been advo-
cated by many [2,7,8] because it makes the operation
technically easier, reduces the risk of complication and
may also reduce the risk of developing systemic metas-
tases [8]. We performed prophylactic surgery on 37 of 93
patients (39%) referred with persistent pain following
radiation therapy. Measures to predict the risk of patho-
logical fracture are available (Mirrels' scoring system [9])
but were not formally evaluated in this study.
We used predominantly rigid intramedullary nailing with
cementation in the canal and this has been successful in
our hands. It is chosen when there is sufficient normal
proximal and distal bone for the rod to span. If this is the
case, then it is highly likely that the rotator cuff will be left
intact apart from a lateral entry point for the nail which is
easily repaired. These patients may be reassured that their
shoulder function can be mostly preserved. Only 8% had
any persistent pain and 6% restricted function of the
affected limb. We have been unable to find any compara-
ble reports of this technique in the literature. There areInternational Seminars in Surgical Oncology 2006, 3:5 http://www.issoonline.com/content/3/1/5
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numerous reports of flexible intramedullary nailing using
Hackethal [10] or Rush rods [4] to good effect, however
we believe that rigid intramedullary nailing provides a
more durable and stable construct to allow early mobili-
zation. An alternative to cementation is the use of rigid
intramedullary nailing with interlocking screws. Dijkstra
et. al. [2] reported 88% of patients achieving good pain
relief and 94% with good function following this tech-
nique. However, there were 3 failures of fixation due to
angulation, rotation and refracture. There were no failures
of fixation using our technique. We used cement in con-
junction with rod fixation for a number of reasons. These
included strengthening the residual bone, enhancing fixa-
tion of the rod along its whole length not just at its ends,
thus providing rotational stability [8,11,12], and also for
the thermonecrotic effect of cement on tumor cells as the
cement cures [11]. The need for cross bolting is obviated,
minimizing the creation of new defects and thus weak-
nesses in the remaining bone.
From our series, 3 out of 51 cases (5.8%) of intramedul-
lary fixation developed transient radial nerve palsy. Only
1 was from using the Alta nail with cement. The other 2
were from the Fixion inflatable nail. There were only 4 Fix-
ion nails inserted in our series and the reason for the
higher incidence of nerve palsies is unclear. The numbers
are too small to draw any meaningful conclusions at this
stage. There has been one report of the Fixion inflatable
nail being used in 23 cases for pathologic fractures of the
humerus in a series by Franck et. al. [13] with no compli-
cations. We believe that the fixation achieved by inflating
the nail is not rigid enough to take into account the pro-
gressive nature of the metastatic deposit. This can poten-
tially lead to loosening of the nail as the deposit enlarges.
Our incidence of radial nerve palsies (5.8%) is slightly
higher than that reported from other series in which
intramedullary nailing was used to treat non pathologic
humeral fractures. Rommens et. al. [14] had a rate of 4.7%
for retrograde nailing and Demirel et.al. [15] a rate of
3.5% for antegrade nailing. The higher rate in our study
reflects the difficulties associated with tumour surgery, in
particular scarring around the area as a result of radiother-
apy and the soft tissue component of the tumour poten-
tially involving the nerve.
Plate fixation should generally be avoided for diaphyseal
lesions as the screws are put into structurally inadequate
bone [16]. We performed only 2 in severely comminuted
diaphyseal fractures. Dijkstra et al [2] showed no differ-
Survival curve Figure 3
Survival curve. Kaplan-Meier survival curve for patients 
with metastases to the shoulder girdle in the first 12 months 
after operation.
Radiograph of Alta humeral nail Figure 2
Radiograph of Alta humeral nail. Post operative radio-
graph of the Alta humeral nail inserted for treatment of a 
pathological fracture of the humeral diaphysis. Cement can 
be seen in situ around the nail which is injected via the prox-
imal entry hole prior to insertion of the nail.International Seminars in Surgical Oncology 2006, 3:5 http://www.issoonline.com/content/3/1/5
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ence in terms of pain relief, function and complications
between intramedullary fixation with interlocking screws
versus plating and hence advocated either technique for
use in midshaft fractures. However, they suggest that post
operative radiation not be used for plate osteosynthesis
due to osteoporosis and impaired bone healing, which is
important for adequate screw fixation. The majority of our
patients who were well enough underwent post operative
radiotherapy to the affected area, which we believe is an
important adjunctive treatment to the surgery.
The aim of treatment of proximal humeral lesions is to
regain shoulder stability and pain relief. Functional results
are usually poor due to extensive destruction of the rotator
cuff soft tissues [16]. In our results, the outcome of proxi-
mal humeral resections and reconstructions was fair, with
35% reporting restricted function. Persistent pain was
reported in only 13% of cases. In 2 cases the prosthesis
was high riding, resulting in restricted mobility. Patients
need to be made aware of the aims of treatment (pain
relief and stability) and the likelihood of persistent shoul-
der stiffness after the operation prior to obtaining consent
for this type of procedure.
Distal humeral lesions were managed predominantly
with plate osteosynthesis but if there were more complex
distal humeral fractures, then these required more exten-
sive resection and reconstruction with total elbow replace-
ments. Significant pain remained in half of our patients
after elbow resection and reconstruction, but the few
numbers make a firm conclusion difficult. There was only
one nerve palsy in this group of patients (25%). Ross et al
[17] reported a 31% incidence of nerve palsies in their
series of custom built endoprothesis incorporating a
hinged elbow to replace large distal humeral lesions.
Conclusion
Metastatic disease to the upper limb should be treated sur-
gically. The majority of patients will survive for a signifi-
cant time after surgery and hence a stable and painfree
limb should be the goal. Our preferred technique for dia-
physeal lesions is rigid intramedullary nailing with meth-
ylmethacrylate cement inserted into the canal. This
provides a durable and stable fixation allowing excellent
pain relief, early mobilization and the potential for fur-
ther adjuvant radiotherapy. Proximal humeral lesions are
generally treated with resection and prosthesis, with good
pain control but poor functional outcome. Patients need
to be aware that a stiff shoulder may result from surgery in
this area and the main goal of treatment is pain relief.
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Table 3: Complications
Operation Complication n
Operation Complication n
Nerve palsy 3
Fat embolus 1
Wound infection 1
Plate fixation n 4
Nerve palsy 2
Fat embolus 1
Plate loosening 1
Resection alone n 1
Wound infection 1
Proximal humeral resection n 5
Intraoperative bleeding 1
Myocardial infarct 1
Stitch abscess 1
High riding prosthesis 1
Proximal migration of prosthesis 1
Distal humeral resection n 1
Nerve palsy 1
Table 2: Outcome versus procedure
n Persistent pain Restricted 
function
Revision Death prior to 
review
No data
Intramedullary rod 51 4 (8%) 3 (6%) 1 (2%) 16 (31%) 8 (15%)
Plate osteosynthesis 8 1 (13 %) 1 (13 %) 0 3 (38 %) 0
Proximal prosthesis 22 3 (13%) 8 (36 %) 0 2 (9%) 5 (22%)
M i d s h a f t  p r o s t h e s i s 200000
Distal prosthesis 4 1 (25%) 1 (25%) 1 (25%) 0 0
Resection alone 2 No data 1 (25%) 0 1 (25%) 2 (50%)
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